Data for: Validity of targeted next generation sequencing in routine care for identifying clinically relevant molecular profiles in non-small cell lung cancer: results of a 2 years experience on 1343 samples

Published: 29 August 2018| Version 1 | DOI: 10.17632/4vmd7bxdct.1
Contributors:
helene blons,
Marc Barritault,
Véronique Giraudet,
Catherine Julie,
William Digan,
Alain Cazier,
Jean Pastre,
Laure Gibault,
Alice Guyard,
Bastien Rance,
Pierre Laurent-Puig,
Elizabeth Fabre,
Stéphane Jouveshomme,
Anne Tallet,
Nicolas Pecuchet,
Véronique Duchatelle,
Francoise LE PIMPEC-BARTHES,
Antoine Legras,
Etienne Giroux Leprieur

Description

1343 NSCLC patients. Molecular diagnosis, CAST vs NGS. Description of molecular alterations (alterations associations, identifications of new actionable targets) using NGS.

Files

Categories

Molecular Biology, Lung Cancer

License